157 related articles for article (PubMed ID: 36417267)
21. Physical activity and the risk of SARS-CoV-2 infection, severe COVID-19 illness and COVID-19 related mortality in South Korea: a nationwide cohort study.
Lee SW; Lee J; Moon SY; Jin HY; Yang JM; Ogino S; Song M; Hong SH; Abou Ghayda R; Kronbichler A; Koyanagi A; Jacob L; Dragioti E; Smith L; Giovannucci E; Lee IM; Lee DH; Lee KH; Shin YH; Kim SY; Kim MS; Won HH; Ekelund U; Shin JI; Yon DK
Br J Sports Med; 2022 Aug; 56(16):901-912. PubMed ID: 34301715
[TBL] [Abstract][Full Text] [Related]
22. Post-acute sequelae of covid-19 six to 12 months after infection: population based study.
Peter RS; Nieters A; Kräusslich HG; Brockmann SO; Göpel S; Kindle G; Merle U; Steinacker JM; Rothenbacher D; Kern WV;
BMJ; 2022 Oct; 379():e071050. PubMed ID: 36229057
[TBL] [Abstract][Full Text] [Related]
23. Ear nose throat-related symptoms with a focus on loss of smell and/or taste in COVID-19 patients.
Sakalli E; Temirbekov D; Bayri E; Alis EE; Erdurak SC; Bayraktaroglu M
Am J Otolaryngol; 2020; 41(6):102622. PubMed ID: 32629147
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of Persisting and New Symptoms Following Recovery from COVID-19 in the Jordanian Population.
M Jaber H; Abusamak M; N Obeid S; Heissat N; Qashou R; Ab Shtaiyat M; Alasad I; Aldaghlise D
Med J Islam Repub Iran; 2023; 37():105. PubMed ID: 38021384
[TBL] [Abstract][Full Text] [Related]
25. Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study.
Haddad A; Janda A; Renk H; Stich M; Frieh P; Kaier K; Lohrmann F; Nieters A; Willems A; Huzly D; Dulovic A; Schneiderhan-Marra N; Jacobsen EM; Fabricius D; Zernickel M; Stamminger T; Bode SFN; Himpel T; Remppis J; Engel C; Peter A; Ganzenmueller T; Hoffmann GF; Haase B; Kräusslich HG; Müller B; Franz AR; Debatin KM; Tönshoff B; Henneke P; Elling R
EBioMedicine; 2022 Oct; 84():104245. PubMed ID: 36155957
[TBL] [Abstract][Full Text] [Related]
26. Functional gastrointestinal and somatoform symptoms five months after SARS-CoV-2 infection: A controlled cohort study.
Noviello D; Costantino A; Muscatello A; Bandera A; Consonni D; Vecchi M; Basilisco G
Neurogastroenterol Motil; 2022 Feb; 34(2):e14187. PubMed ID: 34060710
[TBL] [Abstract][Full Text] [Related]
27. Independent Role of Severe Obesity as a Risk Factor for COVID-19 Hospitalization: A Spanish Population-Based Cohort Study.
Fresán U; Guevara M; Elía F; Albéniz E; Burgui C; Castilla J;
Obesity (Silver Spring); 2021 Jan; 29(1):29-37. PubMed ID: 32885905
[TBL] [Abstract][Full Text] [Related]
28. ABO Blood Groups and Incidence of COVID-19 in the Mass Gathering Events in Borriana (Spain), March 2020: A Retrospective Cohort Study.
Domènech-Montoliu S; Puig-Barberà J; Guerra-Murcia O; Pac-Sa MR; Orrico-Sanchéz A; Gómez-Lanas L; Sala-Trull D; Domènech-Leon C; Del Rio-González A; Sánchez-Urbano M; Satorres-Martinez P; Latorre-Poveda M; Ferrando-Rubert S; Aparisi-Esteve L; Badenes-Marques G; Blasco-Gari R; Casanova-Suarez J; Fontal-Carcel M; Gil-Fortuño M; Hernández-Pérez N; Jovani-Sales D; López-Diago L; Notari-Rodríguez C; Pérez-Olaso O; Romeu-Garcia MA; Ruíz-Puig R; Arnedo-Pena A
Epidemiologia (Basel); 2023 Jan; 4(1):63-73. PubMed ID: 36810454
[TBL] [Abstract][Full Text] [Related]
29. Clinical and epidemiological aspects of SARS-CoV-2 infection among pregnant and postpartum women in Mozambique: a prospective cohort study.
Charles CM; Osman NB; Arijama D; Matingane B; Sitoé T; Kenga D; Lorenzoni C; Luís E; Pacagnella RC; Sacarlal J;
Reprod Health; 2022 Jul; 19(1):164. PubMed ID: 35854384
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
31. Predictors of chronic COVID-19 symptoms in a community-based cohort of adults.
Silverberg JI; Zyskind I; Naiditch H; Zimmerman J; Glatt AE; Pinter A; Theel ES; Joyner MJ; Hill DA; Lieberman MR; Bigajer E; Stok D; Frank E; Rosenberg AZ
PLoS One; 2022; 17(8):e0271310. PubMed ID: 35925904
[TBL] [Abstract][Full Text] [Related]
32. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic.
Balachandren N; Davies MC; Hall JA; Stephenson JM; David AL; Barrett G; O'Neill HC; Ploubidis GB; Yasmin E; Mavrelos D
Hum Reprod; 2022 May; 37(6):1126-1133. PubMed ID: 35389480
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of Loss of Smell and/or Taste and other Otorhinolaryngology Symptoms in COVID-19 Patients.
Shrestha I; Mishra A; Mishra A; Bista M; Acharya J
Kathmandu Univ Med J (KUMJ); 2021; 19(74):173-179. PubMed ID: 34819431
[TBL] [Abstract][Full Text] [Related]
35. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020.
Zambrano LD; Ellington S; Strid P; Galang RR; Oduyebo T; Tong VT; Woodworth KR; Nahabedian JF; Azziz-Baumgartner E; Gilboa SM; Meaney-Delman D;
MMWR Morb Mortal Wkly Rep; 2020 Nov; 69(44):1641-1647. PubMed ID: 33151921
[TBL] [Abstract][Full Text] [Related]
36. Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: An Epidemio-Clinical Study.
Bhandari S; Singh A; Sharma R; Rankawat G; Banerjee S; Gupta V; Dube A; Kakkar S; Sharma S; Keswani P; Agrawal A; Tak A; Nawal CL
J Assoc Physicians India; 2020 Jun; 68(6):13-19. PubMed ID: 32610873
[TBL] [Abstract][Full Text] [Related]
37. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study.
Cohen K; Ren S; Heath K; Dasmariñas MC; Jubilo KG; Guo Y; Lipsitch M; Daugherty SE
BMJ; 2022 Feb; 376():e068414. PubMed ID: 35140117
[TBL] [Abstract][Full Text] [Related]
38. Association of BNT162b2 Vaccine Third Dose Receipt With Incidence of SARS-CoV-2 Infection, COVID-19-Related Hospitalization, and Death Among Residents of Long-term Care Facilities, August to October 2021.
Muhsen K; Maimon N; Mizrahi AY; Varticovschi B; Bodenheimer O; Cohen D; Dagan R
JAMA Netw Open; 2022 Jul; 5(7):e2219940. PubMed ID: 35796153
[TBL] [Abstract][Full Text] [Related]
39. Severe Fatigue in the First Year Following SARS-CoV-2 Infection: A Prospective Cohort Study.
Verveen A; Wynberg E; van Willigen HDG; Boyd A; de Jong MD; de Bree G; Davidovich U; Lok A; Moll van Charante EP; Knoop H; Prins M; Nieuwkerk P;
Open Forum Infect Dis; 2022 May; 9(5):ofac127. PubMed ID: 35415196
[TBL] [Abstract][Full Text] [Related]
40. Long-lasting Symptoms After an Acute COVID-19 Infection and Factors Associated With Their Resolution.
Robineau O; Zins M; Touvier M; Wiernik E; Lemogne C; de Lamballerie X; Blanché H; Deleuze JF; Saba Villarroel PM; Dorival C; Nicol J; Gomes-Rima R; Correia E; Coeuret-Pellicer M; Druesne-Pecollo N; Esseddik Y; Ribet C; Goldberg M; Severi G; Carrat F;
JAMA Netw Open; 2022 Nov; 5(11):e2240985. PubMed ID: 36350653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
